Related Experiment Video
Updated: Oct 20, 2025

06:51
Techniques to Induce and Quantify Cellular Senescence
Published on: May 1, 2017
34.1K
CCNB2/SASP/Cathepsin B & PGE2 Axis Induce Cell Senescence Mediated Malignant Transformation
Ying Wang1, Hanbing Zhang2, Minglei Wang3
1Wuxi Cancer Institute, Affiliated Hospital of Jiangnan University, Wuxi 214062, Jiangsu, China.
International Journal of Biological Sciences
|September 13, 2021
Summary
Cyclin B2 (CCNB2) drives malignant transformation in glioma by inducing a senescence-associated secretory phenotype (SASP). This pathway, involving Cathepsin B and PGE2, promotes tumor invasion and proliferation, offering new therapeutic targets.
Area of Science:
- Neuro-oncology
- Molecular Biology
- Cellular Senescence
Background:
- Glioma is a frequent and aggressive adult brain tumor with high mortality.
- Mechanisms driving glioma's malignant transformation are not fully understood.
- Identifying key regulators of glioma progression is crucial for therapeutic development.
Purpose of the Study:
- To identify key factors regulating tumor progression and malignant transformation in glioma.
- To investigate the role of CCNB2 in glioma pathogenesis.
- To elucidate the link between senescence and glioma malignancy.
Main Methods:
- Comparative gene expression profiling of 693 glioma patients (High-Grade Glioma vs. Low-Grade Glioma).
- Analysis of CCNB2's role in inducing senescence-associated secretory phenotype (SASP).
- Assessment of SASP cytokines, Cathepsin B, and PGE2 in mediating malignant progression.
Main Results:
- CCNB2 was identified as a key factor in glioma malignant transformation.
- CCNB2 induces a senescence-associated secretory phenotype (SASP) in glioma cells.
- Malignant progression, including invasion and proliferation, was mediated by secreted SASP cytokines, Cathepsin B, and PGE2.
Conclusions:
- A novel link between senescence, the CCNB2/SASP/Cathepsin B & PGE2 axis, and glioma malignant transformation was discovered.
- These findings offer new insights for developing therapeutic strategies against glioma aggressiveness.
- Targeting the CCNB2/SASP pathway may represent a promising approach for glioma treatment.
Related Concept Videos
Replicative Cell Senescence
3.9K
Replicative cell senescence is a property of cells that allows them to divide a finite number of times throughout the organism's lifespan while preventing excessive proliferation. Replicative senescence is associated with the gradual loss of the telomere — short, repetitive DNA sequences found at the end of the chromosomes. Telomeres are bound by a group of proteins to form a protective cap on the ends of chromosomes. Embryonic stem cells express telomerase — an enzyme that adds...
3.9K
Abnormal Proliferation
4.7K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.7K
Mitogens and the Cell Cycle
7.2K
Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
7.2K
The Intrinsic Apoptotic Pathway
7.1K
Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
7.1K
Negative Regulator Molecules
36.7K
Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.
36.7K
DNA Damage can Stall the Cell Cycle
9.6K
In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...
9.6K

